Cargando…

Comparison of oral dydrogesterone with suppository vaginal progesterone for luteal-phase support in in vitro fertilization (IVF): A randomized clinical trial

Background: Luteal phase support is mandatory in assisted reproductive technologies (ART) for optimizing outcome, so the luteal phase is supported with either progesterone, addition of estradiol to progesterone, hCG or gonadotropin releasing hormone (GnRH) agonists. Supplementation of luteal phase w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salehpour, Saghar, Tamimi, Maryam, Saharkhiz, Nasrin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Research and Clinical Center for Infertility 2013
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941387/ https://www.ncbi.nlm.nih.gov/pubmed/24639716

Ejemplares similares

Comparison of Subcutaneous and Vaginal Progesterone Used for Luteal Phase Support in Patients Undergoing Intracytoplasmic Sperm Injection Cycles
por: Salehpour, Saghar, et al.
Publicado: (2021)

Do early luteal serum progesterone levels predict the reproductive outcomes in IVF with oral dydrogesterone for luteal phase support?
por: Netter, Antoine, et al.
Publicado: (2019)

A Comparison of Oral Dydrogesterone with Vaginal Progesterone for Luteal-Phase Support in In vitro Fertilization: A Randomized Controlled Trial
por: Naghshineh, Elham, et al.
Publicado: (2023)

Dydrogesterone as an oral alternative to vaginal progesterone for IVF luteal phase support: A systematic review and individual participant data meta-analysis
por: Griesinger, Georg, et al.
Publicado: (2020)

Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial
por: Griesinger, Georg, et al.
Publicado: (2018)

A randomised control trial on oral dydrogesterone versus micronized vaginal progesterone pessary for luteal phase support in in vitro fertilization cycles
por: Ikechebelu, Joseph Ifeanyichukwu, et al.
Publicado: (2023)

A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization
por: Tournaye, Herman, et al.
Publicado: (2017)

Intramuscular progesterone (Gestone) versus vaginal progesterone suppository (Cyclogest) for luteal phase support in cycles of in vitro fertilization–embryo transfer: patient preference and drug efficacy
por: Zaman, Amal Yaseen, et al.
Publicado: (2017)

Oral dydrogesterone vs. vaginal progesterone capsules for luteal-phase support in women undergoing embryo transfer: a systematic review and meta-analysis
por: Barbosa, Marina Wanderley Paes, et al.
Publicado: (2018)

The Future of Luteal Phase Support in ART and the Role of Dydrogesterone
por: Drakopoulos, Panagiotis, et al.
Publicado: (2021)

The addition of dydrogesterone improves the outcomes of pregnant women with low progesterone levels when receiving vaginal progesterone alone as luteal support in HRT‐FET cycles
por: Toriumi, Rena, et al.
Publicado: (2023)

Comparison of oral dydrogesterone with vaginal progesteronefor luteal support in IUI cycles: a randomized clinical trial
por: Khosravi, Donya, et al.
Publicado: (2015)

Premature progesterone rise at human chorionic gonadotropin triggering day has no correlation with intracytoplasmic sperm injection outcome
por: Saharkhiz, Nasrin, et al.
Publicado: (2015)

Supplementary dydrogesterone is beneficial as luteal phase support in artificial frozen-thawed embryo transfer cycles compared to micronized progesterone alone
por: Vidal, Angela, et al.
Publicado: (2023)

Systematic use of long-acting intramuscular progesterone in addition to oral dydrogesterone as luteal phase support for single fresh blastocyst transfer: A pilot study
por: Simon, Virginie, et al.
Publicado: (2022)

Luteal phase bleeding after IVF cycles: comparison between progesterone vaginal gel and intramuscular progesterone and correlation with pregnancy outcomes
por: Jabara, Sami, et al.
Publicado: (2009)

Progesterone for Luteal Phase Support in In Vitro Fertilization: Comparison of Vaginal and Rectal Pessaries to Vaginal Capsules: A Randomized Controlled Study
por: Khrouf, Mohamed, et al.
Publicado: (2017)

A randomized, controlled trial comparing the efficacy and safety of aqueous subcutaneous progesterone with vaginal progesterone for luteal phase support of in vitro fertilization
por: Baker, Valerie L., et al.
Publicado: (2014)

Subcutaneous progesterone versus vaginal progesterone for luteal phase support in in vitro fertilization: A retrospective analysis from daily clinical practice
por: Schütt, Marcel, et al.
Publicado: (2021)

The Influence of Oral Dydrogesterone and Vaginal Progesterone on Threatened Abortion: A Systematic Review and Meta-Analysis
por: Lee, Hee Joong, et al.
Publicado: (2017)

Adding Weekly Intramuscular Progesterone to a Twice Daily Vaginal Progesterone Capsule for Luteal Phase Support in IVF/ICSI Cycles Results in Similar Live Birth Rates
por: Gari, Salwa, et al.
Publicado: (2022)

The Role of Dydrogesterone in the Management of Luteal Phase Defect: A Comprehensive Review
por: Muneeba, Shaikh, et al.
Publicado: (2023)

Patients’ administration preferences: progesterone vaginal insert (Endometrin®) compared to intramuscular progesterone for Luteal phase support
por: Beltsos, Angeline N, et al.
Publicado: (2014)

The effect of testosterone gel on fertility outcomes in women with a poor response in in vitro fertilization cycles: A pilot randomized clinical trial
por: Saharkhiz, Nasrin, et al.
Publicado: (2018)

Treatment results of high dose cabergoline as an adjuvant therapy in six patients with established severe ovarian hyper stimulation syndrome
por: Saharkhiz, Nasrin, et al.
Publicado: (2014)

Subclinical hypothyroidism and insulin resistance in polycystic ovary syndrome: is there a relationship?
por: Enzevaei, Anahita, et al.
Publicado: (2014)

Luteal Phase Support in assisted reproductive technology treatment: focus on Endometrin® (progesterone) vaginal insert
por: Check, Jerome H
Publicado: (2009)

Comparison between Conventional Blind Embryo Transfer and Embryo Transfer Based on Previously Measured Uterine Length
por: Saharkhiz, Nasrin, et al.
Publicado: (2014)

Addition of intramuscular to vaginal progesterone for luteal phase support in fresh embryo transfer cycles: A cross-sectional study
por: Jalaliani, Samaneh, et al.
Publicado: (2022)

Co-administration of GnRH agonists with vaginal progesterone compared to vaginal progesterone in luteal phase support of the frozen-thawed embryo transfer cycle: An RCT
por: Zareii, Afsoon, et al.
Publicado: (2021)

A questionnaire-based audit to assess overall experience and convenience among patients using vaginal progesterone tablets (Lutigest(®)) for luteal phase support during IVF treatment
por: Heine, Polly, et al.
Publicado: (2017)

Subcutaneous progesterone versus vaginal progesterone for luteal-phase support in frozen-thawed embryo transfer: A cross-sectional study
por: Aflatoonian, Abbas, et al.
Publicado: (2021)

Subcutaneous Progesterone Is Effective and Safe for Luteal Phase Support in IVF: An Individual Patient Data Meta-Analysis of the Phase III Trials
por: Doblinger, Jakob, et al.
Publicado: (2016)

Efficacy of daily GnRH agonist for luteal phase support following GnRH agonist triggered ICSI cycles versus conventional strategy: A Randomized controlled trial
por: Salehpour, Saghar, et al.
Publicado: (2021)

Phase III trial of 8% vaginal progesterone gel for luteal phase support in Japanese women undergoing in vitro fertilization and fresh embryo transfer cycles
por: Kokeguchi, Shoji, et al.
Publicado: (2016)

Efficacy, safety and tolerability of progesterone vaginal pessaries versus progesterone vaginal gel for luteal phase support after in vitro fertilisation: a randomised controlled trial
por: Saunders, Helen, et al.
Publicado: (2020)

Vaginal micronized progesterone capsule versus vaginal progesterone gel for lutheal support in normoresponder IVF/ICSI-ET cycles
por: Sofuoglu, Kenan, et al.
Publicado: (2015)

Antithyroid peroxidase antibodies in women with polycystic ovary syndrome
por: Salehpour, Saghar, et al.
Publicado: (2013)

Treatment of thin endometrium with autologous platelet-rich plasma: a pilot study
por: Zadehmodarres, Shahrzad, et al.
Publicado: (2017)

Progesterone Hypersensitivity: A Challenge for Luteal Support
por: Gupta, Astha, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hrjtfba852faqh9r7mte7hce5f